LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering

Clinical trial NCT06865885 · RECRUITING

Trial details

NCT number: NCT06865885
Sponsor: University of California, San Diego
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Drug Interactions Primary Prevention Cardiometabolic Syndrome LDL-Cholersterol Lowering

Start date: 2025-04-02
Primary completion: 2026-12-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.